General Information
| Application | Inhibitor |
|---|
| Description | Sitravatinib is a novel small molecule inhibitor targeting multiple RTKs involved in driving sarcoma cell growth with IC50 of 3980 nmol/L |
|---|
| Cas NO. | 1123837-84-2 |
|---|
| Purity | 98 % |
|---|---|
| Molecular Weight |
629.68 |
| Formula | C33H29F2N5O4S |
| Solubility |
DMSO : >32 mg/ml |
|---|
| Storage |
Powder : -20°C for 3 years |
|---|
| Alias | MGCD516; MG516 |
|---|
|
|
1 mg |
5 mg |
10 mg |
|
|
1 mM |
1.5881 mL | 7.9405 mL | 15.8811 mL | |
| 5 mM | 0.3176 mL | 1.5881 mL | 3.1762 mL | |
| 10 mM | 0.1588 mL | 0.7941 mL | 1.5881 mL | |
.png)